Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, February 6, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Sun, February 5, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Mark Massaro Maintained (BNGO) at Strong Buy and Held Target at $35 on, Feb 5th, 2023
Mark Massaro of BTIG, Maintained "Bionano Genomics, Inc." (BNGO) at Strong Buy and Held Target at $35 on, Feb 5th, 2023.
Mark has made no other calls on BNGO in the last 4 months.
There is 1 other peer that has a rating on BNGO. Out of the 1 peers that are also analyzing BNGO, 0 agree with Mark's Rating of Hold.
This is the rating of the analyst that currently disagrees with Mark
- Sung Ji Nam of "Scotiabank" Initiated at Buy and Held Target at $40 on, Thursday, January 5th, 2023
